文献速递角膜与眼表疾病眼外伤

VISTA对同种角膜移植物存活及免疫豁免维持至关重要

VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

该研究探讨VISTA在角膜同种异体移植免疫豁免中的作用。小鼠角膜表达VISTA mRNA且定位于基质CD11b+细胞;抗VISTA单抗处理受者后移植物存活缩短,前房相关免疫偏离(ACAID)诱导效率降低,脾脏CD8+及CD8+CD103+调节性T细胞比例显著下降。结论提示VISTA可能通过参与同种特异性ACAID维持角膜移植免疫豁免。

要点

  • VISTA在角膜组成性表达,定位于基质CD11b+细胞。
  • 阻断VISTA缩短小鼠角膜同种移植存活时间并削弱ACAID诱导。
  • 抗VISTA处理降低脾脏CD8+及CD8+CD103+调节性T细胞比例。

核心结论

  • VISTA可能通过参与同种特异性ACAID抑制T细胞浸润角膜,在角膜同种移植物的接受中发挥重要作用。

研究设计与样本

  • 采用逆转录PCR检测小鼠眼VISTA mRNA表达;将C57BL/6小鼠角膜原位移植至BALB/c野生型受者并用抗VISTA单抗处理,评估移植物存活。
  • 另一组BALB/c小鼠经抗VISTA单抗或大鼠IgG处理后前房注射C57BL/6脾细胞,评估同种特异性ACAID诱导,并用流式细胞术检测脾脏CD4+和CD8+ T细胞。

主要发现

  • VISTA mRNA在角膜组成性表达,且VISTA表达定位于角膜基质CD11b+细胞。
  • 抗VISTA单抗处理的同种移植物存活低于对照。
  • 抗VISTA单抗处理的BALB/c小鼠ACAID诱导效率低于对照。
  • 抗VISTA单抗处理的BALB/c小鼠脾脏CD8+ T细胞及CD8+CD103+ T细胞(CD8+调节性T细胞)比例显著低于对照。

临床怎么用

  • 角膜移植受者中VISTA通路可能影响免疫豁免与移植物存活,但原文未提供临床干预方案或阈值。

局限性

  • 原文未报告样本量、具体P值及效应量等统计细节。
  • 研究为小鼠模型,结论外推至临床需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel immune checkpoint receptor and ligand for regulating T cell proliferation and cytokine production. The purpose of the present study was to determine the role of VISTA in the immune privilege of corneal allografts. METHODS: Expression of VISTA mRNA in mouse eyes was assessed with reverse-transcription PCR. Corneas of C57BL/6 mice were orthotopically transplanted into the eyes of BALB/c wild-type recipients treated with anti-VISTA mAb, and graft survival was assessed. A separate set of BALB/c mice treated with anti-VISTA mAb or rat IgG received injection of C57BL/6 splenocytes into the anterior chamber, and induction of allospecific anterior chamber-associated immune deviation (ACAID) was assessed. CD4+ and CD8+ T cells in the spleen were assessed with flow cytometry. RESULTS: VISTA mRNA was constitutively expressed in the cornea, and the expression of VISTA was localized to CD11b+ cells on the corneal stroma. Survival of allografts treated with anti-VISTA mAb was less than that of the control. ACAID was induced less efficiently in BALB/c mice treated with VISTA mAb. The proportions of CD8+ T cells and CD8+ CD103+ T cells (CD8+ T regulatory cells) in the spleen of BALB/c mice treated with anti-VISTA mAb were significantly lower than those of the control. CONCLUSIONS: VISTA may play an essential role in the acceptance of corneal allografts via involvement with allospecific ACAID, which suppresses T cell infiltration into the cornea.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kunishige T, Taniguchi H, Ohno T, et al. VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege. Invest Ophthalmol Vis Sci. 2019. PMID: 31790558. doi:10.1167/iovs.19-27322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。